Mark Your Calendar for BPI Europe 2025
12-15 May 2025Congress Center Hamburg, GermanySponsors
Charles River Laboratories
Profile
Only 0.01% of drug candidates entering clinical trials reach the market. With Charles River supporting >80% of drugs approved by the FDA over the last five years, improve your odds, leverage our experience, and expedite your time to market.
- Our comprehensive portfolio supporting proteins, antibodies, vaccines, and cell and gene therapies includes:Cell Bank and Virus Manufacturing
- Biophysical, Molecular, and Genetic Characterization Services
- Biosafety and Viral Clearance Studies
- Bioactivity and Potency Testing
- Stability and QC Testing
- Cell and Gene Therapy CDMO Solutions
Contact us to learn how we can help to get your product to patients faster.
We're bringing you
Viral safety aspects of biological raw materials used to manufacture biologics including advanced therapy medicinal products
, 15:15View Session